Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Mar 19, 2025
PHILADELPHIA, March 19, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today reported financial results and business highlights for the full year 2024.
Read more at globenewswire.com
